Last edition
News about "glaucoma treatment"
Bayer Completes Acquisition of Perfuse Therapeutics
Bayer has completed the acquisition of Perfuse Therapeutics, strengthening its ophthalmology pipeline and expanding its portfolio of innovative eye disease treatments.
Glaucoma Treatment | 19/06/2026 | By News Bureau
Life Biosciences Doses First Patient in Phase 1 ER-100 Optic Neuropathy Trial
Life Biosciences has dosed the first patient in its phase 1 trial of ER-100, an investigational epigenetic restoration therapy for glaucoma and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION). The study marks a key milestone in evaluating a novel approach that targets the underlying causes of age-related vision loss.
Glaucoma Treatment | 09/06/2026 | By News Bureau | 790
Akums Becomes First Indian CDMO to Receive DCGI Approval for Innovative Glaucoma Treatment
Glaucoma ranks as the second leading cause of irreversible but preventable blindness worldwide, with India contributing to 23.5 percent of the global burden.
Glaucoma Treatment | 01/04/2025 | By Abha | 564
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy